Technical Trend Shift and Momentum Analysis
Recent technical assessments reveal that Chandan Healthcare’s price momentum has shifted from mildly bearish to outright bearish. The daily moving averages have turned negative, indicating sustained selling pressure. The stock closed at ₹227.10, down 2.32% from the previous close of ₹232.50, underscoring the weakening trend.
The Moving Average Convergence Divergence (MACD) indicator on the weekly chart remains bearish, signalling that downward momentum is entrenched. Although the monthly MACD does not currently provide a definitive signal, the weekly bearish stance suggests near-term pressure. The Relative Strength Index (RSI) on both weekly and monthly timeframes remains neutral, offering no immediate oversold or overbought signals, which implies that the stock could continue its downward trajectory without a technical bounce.
Bollinger Bands on the weekly chart have turned bearish, with the price likely hugging the lower band, indicating increased volatility and downward pressure. Conversely, the monthly Bollinger Bands show a sideways pattern, suggesting a lack of clear directional momentum over the longer term. The KST (Know Sure Thing) indicator on the weekly timeframe also confirms bearish momentum, reinforcing the negative outlook.
Moving Averages and Volume Indicators
Daily moving averages have deteriorated, with the stock trading below key averages, signalling a bearish trend. This technical weakness is compounded by the absence of any clear trend in the On-Balance Volume (OBV) indicator on both weekly and monthly charts, which suggests that volume is not supporting any meaningful price recovery. The Dow Theory analysis also indicates no discernible trend on weekly or monthly scales, reflecting market indecision or consolidation phases.
Overall, these technical signals collectively point to a challenging environment for Chandan Healthcare, with momentum firmly skewed towards the downside.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Price Performance Relative to Sensex
Chandan Healthcare’s price performance has lagged significantly behind the broader market benchmark, the Sensex. Over the past week, the stock declined by 1.82%, while the Sensex fell by a steeper 2.78%, indicating a relatively better short-term resilience. However, over the one-month horizon, the stock gained 3.16%, contrasting with the Sensex’s 6.79% decline, suggesting some isolated strength in the near term.
Year-to-date (YTD), the stock has underperformed markedly, with a return of -30.03% compared to the Sensex’s -14.19%. This underperformance extends to the one-year period, where Chandan Healthcare’s return of -1.26% pales against the Sensex’s -9.72%. The absence of data for three, five, and ten-year returns for the stock limits long-term comparative analysis, but the Sensex’s robust gains over these periods (14.17%, 27.89%, and 160.38% respectively) highlight the stock’s relative weakness.
Valuation and Market Capitalisation Context
Chandan Healthcare is classified as a micro-cap stock, which typically entails higher volatility and risk compared to larger peers. The company’s 52-week high stands at ₹358.00, while the low is ₹185.40, indicating a wide trading range and significant price fluctuations over the past year. The current price of ₹227.10 is closer to the lower end of this range, reflecting the bearish technical signals and subdued investor sentiment.
The downgrade in Mojo Grade from Hold to Sell on 10 August 2026, accompanied by a low Mojo Score of 31.0, underscores the cautious stance adopted by analysts. This downgrade reflects deteriorating fundamentals and technicals, signalling that investors should exercise prudence.
Why settle for Chandan Healthcare Ltd? SwitchER evaluates this Hospital micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Implications for Investors and Outlook
Given the current technical deterioration and bearish momentum, investors should approach Chandan Healthcare with caution. The absence of strong bullish signals from key indicators such as MACD, RSI, and moving averages suggests limited near-term upside potential. The sideways monthly Bollinger Bands and lack of volume support further imply that any recovery may be muted or short-lived.
Micro-cap stocks like Chandan Healthcare often exhibit heightened sensitivity to market fluctuations and sector-specific developments. The hospital sector itself faces evolving challenges, including regulatory pressures and competitive dynamics, which may weigh on the company’s prospects.
Investors seeking exposure to the healthcare space might consider evaluating alternative stocks with stronger technical profiles and more favourable fundamental metrics. The current Mojo Grade Sell rating and low score reinforce the need for a cautious stance.
Summary
Chandan Healthcare Ltd’s technical parameters have shifted decisively towards bearishness, with multiple indicators confirming negative momentum. The downgrade in Mojo Grade to Sell and the stock’s underperformance relative to the Sensex highlight the challenges ahead. While short-term price movements may see intermittent relief, the overall trend remains unfavourable. Investors are advised to monitor technical signals closely and consider diversification into better-rated healthcare or broader market opportunities.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
